FDA Inspection 1015493 — Stanislav Vohanka, M.D.
The FDA completed an inspection of Stanislav Vohanka, M.D. on April 21, 2017 in Brno. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 21, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brno (Czech Republic)
Additional Details
Clinical Investigator (CI)